Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Post-transplantation cyclophosphamide improves graft-versus-host disease-free, relapse-free survival in HLA-DPB1 mismatched unrelated donor allogeneic transplant
    Meeting Abstract

    McCurdy, S. R.; Solomon, S. R.; Shaffer, B. C.; He, M.; Bolon, Y. T.; Blouin, A. G.; Keyzner, A.; Socola, F. A.; Ibrahim, U.; Zou, J.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Young matched unrelated donors should be prioritized over older-aged matched sibling donors and young haploidentical donors in allogeneic transplantation with post-transplant cyclophosphamide in recipients ≥ 50-years
    Meeting Abstract

    Nath, K.; Zhang, M. J.; Bye, M.; Lee, S.; Bolon, Y. T.; Benjamin, C.; Betts, B.; Gadalla, S.; Marsh, S. G. E.; Mehta, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Superior disease control with younger matched unrelated donor vs older-aged matched sibling donor in recipients ≥ 50-years with ALL, AML, or MDS using CNI-based GVHD prophylaxis
    Meeting Abstract

    Nath, K.; Zhang, M. J.; Bye, M.; Lee, S.; Bolon, Y. T.; Benjamin, C.; Betts, B.; Gadalla, S.; Marsh, S. G. E.; Mehta, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Outcomes in African-American (AA) and White patients with newly diagnosed multiple myeloma receiving RVd-alone vs RVd + ASCT in determination: Efficacy, safety, and second primary malignancies (SPMS)
    Meeting Abstract

    Richardson, P. G.; Zonder, J. A.; Khan, A. M.; Jacobus, S. J.; Hassoun, H.; Anderson, L. D. Jr; Merz, L. E.; Zon, R. L.; Efebera, Y.; Buck, T.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Recirculating regulatory T cells mediate thymic regeneration
    Meeting Abstract

    Lemarquis, A. L.; Argyropoulos, K.; Kousa, A.; Jahn, L.; Gipson, B.; Dudakov, J.; DeWolf, S.; van den Brink, M.
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Galectin-9 released by chemotherapy-damaged intestinal epithelium attracts and stimulates activation of allo T cells
    Meeting Abstract

    Jansen, S. A.; Cutilli, A.; de Koning, C.; van Hoesel, M.; Sierra, L. S.; Nierkens, S.; Mokry, M.; Nieuwenhuis, E.; Hanash, A.; Mocholi, E.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Phase II study of pharmacokinetic model-based ATG dosing to improve survival through enhanced immune reconstitution in patients undergoing ex vivo CD34-selected allogeneic HCT (PRAISE-IR)
    Meeting Abstract

    Scordo, M.; Perales, M. A.; Mauguen, A.; Lin, A.; Kunvarjee, B.; Bieler, J.; Nguyen, L. K.; Paes Pena, M.; Cho, C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Large-scale TCR deep sequencing reveals a T cell diversity bottleneck with post-transplant cyclophosphamide with implications for efficacy and toxicity: Results of the BMT-CTN 1801 study
    Meeting Abstract

    Kean, L.; Siegel, S.; Schmalz, J.; Bien, S.; DeWolf, S.; Dong, J.; Scheffey, D.; Sanders, C.; Robins, H.; Applegate, K.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Site-specific responses and extranodal involvement implications in large B-cell lymphomas treated with CD19-CART therapy
    Meeting Abstract

    Luna de Abia, A.; Devlin, S. M.; Flynn, J.; Corona De Lapuerta, M.; Luttwak, E.; Landego, I.; Dahi, P. B.; Lin, R. J.; Parascondola, A.; Palomba, M. L.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • An open-label, multicenter, phase II study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) part 2
    Meeting Abstract

    Lee, J. Y.; Makker, V.; Oaknin, A.; Oh, D. Y.; Anoka, C.; Jung, L.; Simoes, J.; Puvvada, S. D.; Meric-Bernstam, F.
    Annals of Oncology (2024)

    Fulltext@MSK | Save